Lewes, DE -- (SBWIRE) -- 10/29/2018 -- Global Checkpoint Inhibitors for Treating Cancer market will register a 28.0% CAGR in terms of revenue, reach US$ 20600 million by 2023, from US$ 4690 million in 2017.

Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the "brakes" on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-1/PD-L1 and CTLA-4/B7-1/B7-2.

Those four kinds of checkpoint inhibitors are mainly used to treat melanoma, bladder cancer and others. In 2015, melanoma treatment consumed checkpoint inhibitors took a share of 80.53%. In 2016, melanoma treatment consumed checkpoint inhibitors will be 68153g. Bladder cancer treatment consumed checkpoint inhibitors will be 1978g.

Although YERVOY® (ipilimumab), OPDIVO® (nivolumab), KEYTRUDA® (pembrolizumab) and Tecentriq® (atezolizumab) are four indispensable medicines for cancer treatment, they also has many shortages. Firstly, they all have side effect for patient. Secondly, price of checkpoint inhibitors for treating cancer is too expensive. CTLA-4 inhibitors price is about 118.2 USD/mg in 2016. PD-1 inhibitors price is about 28.6 USD/mg in 2016. PD-L1 inhibitors price is about 30.5 USD/mg in 2016. For most patients, the price is unbearable.

Over the next five years, Study projects that Checkpoint Inhibitors for Treating Cancer will register a 28.0% CAGR in terms of revenue, reach US$ 20600 million by 2023, from US$ 4690 million in 2017.

This report studies the global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top 5 players in each region, with sales, price, revenue and market share from 2013 to 2018, the top players:
Bristol-Myers Squibb(BMS)
Merck
Roche

Market Segment by Regions, this report splits Global into several key Regions, with sales, revenue, market share of top players in these regions, from 2013 to 2018 (forecast), like
North America (United States, Canada and Mexico)
Asia-Pacific (China, Japan, Southeast Asia, India and Korea)
Europe (Germany, UK, France, Italy and Russia etc.)
South America (Brazil, Chile, Peru and Argentina)
Middle East and Africa (Egypt, South Africa, Saudi Arabia)

Split by Product Types, with sales, revenue, price, market share of each type, can be divided into
PD-1 Inhibitors
PD-L1 Inhibitors
CTLA-4 Inhibitors

Split by applications, this report focuses on sales, market share and growth rate in each application, can be divided into
Melanoma Treatment
Bladder Cancer Treatment
Other

Spanning over 125 pages "Forecast of Global Checkpoint Inhibitors for Treating Cancer Market 2023" report covers Checkpoint Inhibitors for Treating Cancer Market Overview, Global Checkpoint Inhibitors for Treating Cancer Sales, Revenue (Value) and Market Share by Players, Global Checkpoint Inhibitors for Treating Cancer Sales, Revenue (Value) by Regions, Type and Application (2013-2018), North America Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales, Revenue and Price, Europe Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales, Revenue and Price, Asia-Pacific Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales, Revenue and Price, South America Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales, Revenue and Price, Middle East & Africa Top 5 Players Checkpoint Inhibitors for Treating Cancer Sales, Revenue and Price, Global Checkpoint Inhibitors for Treating Cancer Players Profiles/Analysis, Global Checkpoint Inhibitors for Treating Cancer Market Forecast (2018-2023), Checkpoint Inhibitors for Treating Cancer Manufacturing Cost Analysis, Industrial Chain, Sourcing Strategy and Downstream Buyers, Marketing Strategy Analysis, Distributors/Traders, Market Effect Factors Analysis, Research Findings and Conclusion, Appendix.

Please visit this link for more details: https://www.marketresearchreports.com/mrrpb2/forecast-global-checkpoint-inhibitors-treating-cancer-market-2023

Find all Pharma and Healthcare Reports at: https://www.marketresearchreports.com/pharma-healthcare

For related reports please visit: https://www.marketresearchreports.com/search/site/Checkpoint%20Inhibitors%20for%20Treating%20Cancer

Read our Interactive Market Research Blog

About MarketResearchReprots.com
MarketResearchReprots.com is world's largest store offering quality market research, SWOT analysis, competitive intelligence and industry reports. We help Fortune 500 to Start-Ups with the latest market research reports on global & regional markets which comprise key industries, leading market players, new products and latest industry analysis & trends.

Contact us for your market research requirements: https://www.marketresearchreports.com/contact